News >

High-Dose Chemotherapy and ASCT Reign Supreme in Frontline Myeloma

Angelica Welch
Published: Monday, Oct 08, 2018

Jeffrey Zonder, MD

Jeffrey Zonder, MD

Among new advances in multiple myeloma, high-dose chemotherapy and autologous stem cell transplant (ASCT) remain the go-to frontline treatment for patients with newly diagnosed multiple myeloma, according to Jeffrey A. Zonder, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication